A Multiclass Radiomics Method-Based WHO Severity Scale for Improving COVID-19 Patient Assessment and Disease Characterization From CT Scans.

Garcia Henao, John Anderson; Depotter, Arno; Bower, Danielle V; Bajercius, Herkus; Todorova, Plamena Teodosieva; Saint-James, Hugo; de Mortanges, Aurélie Pahud; Barroso, Maria Cecilia; He, Jianchun; Yang, Junlin; You, Chenyu; Staib, Lawrence H; Gange, Christopher; Ledda, Roberta Eufrasia; Caminiti, Caterina; Silva, Mario; Cortopassi, Isabel Oliva; Dela Cruz, Charles S; Hautz, Wolf; Bonel, Harald M; ... (2023). A Multiclass Radiomics Method-Based WHO Severity Scale for Improving COVID-19 Patient Assessment and Disease Characterization From CT Scans. Investigative radiology, 58(12), pp. 882-893. Wolters Kluwer Health 10.1097/RLI.0000000000001005

[img]
Preview
Text
A_Multiclass_Radiomics_Method_Based_WHO_Severity.139.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (3MB) | Preview

OBJECTIVES

The aim of this study was to evaluate the severity of COVID-19 patients' disease by comparing a multiclass lung lesion model to a single-class lung lesion model and radiologists' assessments in chest computed tomography scans.

MATERIALS AND METHODS

The proposed method, AssessNet-19, was developed in 2 stages in this retrospective study. Four COVID-19-induced tissue lesions were manually segmented to train a 2D-U-Net network for a multiclass segmentation task followed by extensive extraction of radiomic features from the lung lesions. LASSO regression was used to reduce the feature set, and the XGBoost algorithm was trained to classify disease severity based on the World Health Organization Clinical Progression Scale. The model was evaluated using 2 multicenter cohorts: a development cohort of 145 COVID-19-positive patients from 3 centers to train and test the severity prediction model using manually segmented lung lesions. In addition, an evaluation set of 90 COVID-19-positive patients was collected from 2 centers to evaluate AssessNet-19 in a fully automated fashion.

RESULTS

AssessNet-19 achieved an F1-score of 0.76 ± 0.02 for severity classification in the evaluation set, which was superior to the 3 expert thoracic radiologists (F1 = 0.63 ± 0.02) and the single-class lesion segmentation model (F1 = 0.64 ± 0.02). In addition, AssessNet-19 automated multiclass lesion segmentation obtained a mean Dice score of 0.70 for ground-glass opacity, 0.68 for consolidation, 0.65 for pleural effusion, and 0.30 for band-like structures compared with ground truth. Moreover, it achieved a high agreement with radiologists for quantifying disease extent with Cohen κ of 0.94, 0.92, and 0.95.

CONCLUSIONS

A novel artificial intelligence multiclass radiomics model including 4 lung lesions to assess disease severity based on the World Health Organization Clinical Progression Scale more accurately determines the severity of COVID-19 patients than a single-class model and radiologists' assessment.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Institute of Diagnostic, Interventional and Paediatric Radiology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology
10 Strategic Research Centers > ARTORG Center for Biomedical Engineering Research > ARTORG Center - AI in Medical Imaging Laboratory
04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > University Emergency Center
10 Strategic Research Centers > ARTORG Center for Biomedical Engineering Research

UniBE Contributor:

Garcia Henao, John Anderson, Depotter, Arno Gerard Albert, Bower, Danielle Vera, Bajercius, Herkus, Todorova, Plamena Teodosieva, Hautz, Wolf, Bonel, Harald Marcel, Reyes, Mauricio, Pöllinger, Alexander

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

1536-0210

Publisher:

Wolters Kluwer Health

Language:

English

Submitter:

Pubmed Import

Date Deposited:

27 Jul 2023 10:13

Last Modified:

11 Nov 2023 00:13

Publisher DOI:

10.1097/RLI.0000000000001005

PubMed ID:

37493348

BORIS DOI:

10.48350/185079

URI:

https://boris.unibe.ch/id/eprint/185079

Actions (login required)

Edit item Edit item
Provide Feedback